Status:
UNKNOWN
Atrial Fibrillation Prediction Trial.
Lead Sponsor:
University of Athens
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
30-80 years
Brief Summary
Atrial Fibrillation (AF) is a common arrhythmia with a prevalence of 1.5-2%. This prevalence increases significantly after 80 years of age. After the appearance of first episode(s) some of the patient...
Detailed Description
Atrial Fibrillation (AF) is a common arrhythmia with a prevalence of 1.5-2%. This prevalence increases significantly after 80 years of age. In the presence of the Arrhythmia the risk of stroke increas...
Eligibility Criteria
Inclusion
- Inclusion criteria is one up to five paroxysmal AF (PAF) episodes during the last three years. Patients during screening must maintaining Sinus Rhythm.
Exclusion
- previous heart surgery, hyperthyroidism, severe diseases of the autonomic nervous system, alcoholism, diseases affecting seriously the survival and absence of adequate cooperation for the study
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02307032
Start Date
September 1 2014
End Date
December 1 2020
Last Update
January 28 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Department, Hippokration Hospital
Athens, Attica, Greece
2
First Department of Cardiology, Medical School, National & Kapodistrian University of Athens
Athens, Attica, Greece
3
Cardiology Department Thriasio Hospital
Eleysina, Attica, Greece
4
Cardiology Department, Sismanogleion Hospital
Marousi, Greece